about
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (...
Read More
4.6M
XNAS Volume
High volume today
XNAS 09 May, 2025 5:30 PM (EDT)
Low Financial Strength
Expensive Valuation
Technically Moderately Bullish
Momentum Trap
These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked.
View Similar
Embed DVM
CorMedix Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..